Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectus Sheath Block in Major Urologic Surgery
NCT03458598Completed
- Sponsor
- University of Alberta
- Start
- Feb 2018
- Primary completion
- Feb 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine and bupivacaine in postoperative pain (2 arms), sponsored by University of Alberta. Primary endpoint: Opioid requirement in first 24 hours after surgery. Started Feb 2018; status: completed.
02
Drugs
ropivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03458598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03458598.